Observational studyJournal of global oncology2019
Patients With Breast Cancer: Report From a National Hospital-Based Cancer Registry in Argentina, 2012 to 2016.
Observational study in Journal of global oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Breast Cancer Heterogeneity in Latin America: A Scoping Review of Clinical-Pathological Characteristics, Molecular Subtypes, and Survival.World journal of surgery · 2025Article
- Trends in breast cancer mortality in Peru and its geographical areas from 2013 to 2022 and prediction until 2027.BMC cancer · 2025Observational
- Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries.SAGE open medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo describe sociodemographic, epidemiologic, and clinical characteristics of patients who were diagnosed with breast cancer and registered in the Institutional Tumor Registry of Argentina (RITA) as of April 2016.
methodsThis was an observational, descriptive case study in patients who were diagnosed with breast cancer between April 2012 and April 2016 and registered in RITA. Quantitative and qualitative analyses were done, including delay from symptoms to first consultation, delay from diagnosis to treatment (opportunities), as well as patients' survival (Kaplan-Meier and log-rank tests).
resultsThere were 4,883 identified patients and 4,950 tumors. The mean age of patients was 57.6 years (median, 56 years); 60% of patients had completed elementary studies, 46.8% had some health coverage, and 85.4% of diagnoses were made by tumor histology (TNM stage: T2 19%, N0 20%, M0 29.1%; clinical stages II and III: 34.7%). In terms of morphology, 89.6% of primary tumors had malignant behavior (76% ductal, 8% lobular); and for immunohistochemistry, 34.3% were estrogen receptor positive/progesterone receptor positive/human epidermal growth factor receptor 2 negative. The longest delays analyzed were from diagnosis date to the beginning of first treatment. Survival rates were 96% for up to 24 months and 84.7% for up to 36 months.
conclusionFor the first time in Argentina, there is systematized information on the care of oncology patients at public health institutions, which is useful for improving patients' care. We found that RITA collects important information for the identification of groups with similar sociodemographic and clinical characteristics that could show different vulnerabilities along the disease process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.